Dr. Mainwaring is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1840 Medical Center Pkwy
Suite 300
Murfreesboro, TN 37129Phone+1 615-848-0488Fax+1 615-904-9061
Education & Training
University of FloridaFellowship, Hematology and Medical Oncology, 1995 - 1998- University of FloridaResidency, Internal Medicine, 1992 - 1995
Wayne State University School of MedicineClass of 1992
Certifications & Licensure
TN State Medical License 2001 - 2023
FL State Medical License 1994 - 2005
Clinical Trials
- Use of Topotecan in Patients With Refractory Acute Leukemia Start of enrollment: 1998 Aug 01
Publications & Presentations
PubMed
- 12 citationsTreatment of refractory acute leukemia with timed sequential chemotherapy using topotecan followed by etoposide + mitoxantrone (T-EM) and correlation with topoisomeras...Mark G. Mainwaring, Lisa M. Rimsza, Sifeng Chen, S. P. Gomez, F. W. Weeks
Leukemia & Lymphoma. 2002-05-01 - 28 citationsPhase II Trial of Docetaxal Plus Imatinib Mesylate in the Treatment of Patients With Metastatic Breast CancerDenise A. Yardley, Howard A. Burris, Tiffanie M. Markus, David R. Spigel, F. Anthony Greco
Clinical Breast Cancer. 2009-11-01 - 6 citationsA Phase II Open Label Study of Everolimus in Combination With Endocrine Therapy in Resistant Hormone Receptor-Positive HER2-Negative Advanced Breast CancerDenise A. Yardley, William Liggett, Mark Mainwaring, Aurelio Castrellon, Laura Blakely
Clinical Breast Cancer. 2020-04-01
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
